Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors
Dalton Transactions · 2024
DOI: 10.1039/d4dt01853b ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Karolina Kowalczyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Spectroscopy, Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, ul. Tamka 12, 91-403 Łódź, Poland. d…. Hauptthemen laut MEDLINE: Dihydropyridines, Kinesins, Drug Design, Ferrous Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Ferrocenyl analogues of CPUYL064 were designed to evaluate the impact of the ferrocenyl group on their antimitotic properties and KSP inhibitory activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Spectroscopy, Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, ul. Tamka 12, 91-403 Łódź, Poland. damian.plazuk@chemia.uni.lodz.pl.
- Cytometry Lab, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, ul. Pomorska 141/143, 90-236 Łódź, Poland.
ORCID-Profile: Andrzej Błauż, Błażej Rychlik, Damian Plażuk
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Kowalczyk, K., Błauż, A., Krawczyk, K., Rychlik, B., & Plażuk, D. (2024). Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors. Dalton Transactions. https://doi.org/10.1039/d4dt01853b
Vancouver
Kowalczyk K, Błauż A, Krawczyk K, Rychlik B, Plażuk D. Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors. Dalton Transactions. 2024. doi:10.1039/d4dt01853b
BibTeX
@article{Kowalczyk2024,
author = {Kowalczyk, Karolina and Błauż, Andrzej and Krawczyk, Krzysztof and Rychlik, Błażej and Plażuk, Damian},
title = {Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors},
journal = {Dalton Transactions},
year = {2024},
doi = {10.1039/d4dt01853b}
}
EUVIMED